Mpox 7-1-7 diagnostic and sequencing targets in the Democratic Republic of the Congo
Abstract
Background: Mpox remains a global public Health concern with the democratic Republic of Congo as Epicenter. The 7-1-7 agenda has as target detection within ≤7 days to respond to outbreaks. The Democratic republic of Congo (DRC), faces persistent transmission linked to gaps in surveillance and laboratory systems. This study assessed the diagnostic yield, timeliness to Mpox diagnosis, sequencing and operational determinants associated with timeliness.
Methods: We conducted a retrospective analysis of National surveillance and Laboratory data (2022-2025) extracted from DHIS-2. Timeliness was defined as difference from symptom onset to Mpox diagnosis or sequencing and categorized as ≤ 7 or ≥ 7 days. Logistic regression estimated crude and adjusted odds ratios (COR, AOR) and statistical significance at p < 0.05. A cascade analysis was used to evaluate attrition across response stages.
Results: A total of 30784 suspected alerts among which 11771(38.2% were validated, 9139 (77.6%) samples collected, and 2829(9.2%) tested, positivity of 951(33.61%) and 386 (40.5%) sequenced. Only 50.6 % of all samples achieved timely OPX diagnosis while 53.9% met sequencing targets. Delays in sample transport ≥3 days (AOR: 0.19, CI: 0.10-0.44, p<0.001), laboratory turnaround time >4 days (AOR: 0.15, CI: .11-0.22)) reduced the odds of timely Mpox diagnosis. Symptom to alert interval within 24-48H, alert to sample collection, Sample reception to analysis were 4.10 (C.I: 2.8-6.01), 1.73 (C.I: 0.83-4.32), 2.75 (1.85-3.5) respectively. Attrition rate between stages were 62%, 69%, 85 % and 59.41% from alerts to Sequencing.
Conclusions: Mpox diagnostic and sequencing timelines in DRC within 7-1-7 framework remains remains suboptimal with operational insufficiencies as determinants. Re-enforcing early detection, specimen transport, decentralized laboratory capacity could be essential to achieve 7-1-7 tarets and improve outbreak response.
Key messages: • Mpox diagnostic and sequencing timelines in the DRC remain suboptimal, with only 50.6% of cases meeting the 7-1-7 target, largely due to significant attrition between alerts and laboratory testing.
• Achieving 7-1-7 targets in DRC reqires addressing operational barriers by decentralizing laboratory capacity and optimizing specimen transport to reduce critical delays in detection and response.
Related
- Knowledge, attitudes, and practices of healthcare professionals on female genital schistosomiasis in the Mabalako health zone, Democratic Republic of the Congo
- Molecular epidemiology of Theileria parva in Eastern Democratic Republic of the Congo: implications for the introduction of the Muguga cocktail vaccine against East Coast Fever.
- Contact in context: How land use histories, sociocultural practices, and animal profiles shape human-animal contact and zoonotic pathogen exposure in a fragmented forest of the Democratic Republic of Congo
- Impact of praziquantel treatment and early reinfection patterns in a mixed Schistosoma mansoni and Schistosoma haematobium infection focus in the Democratic Republic of Congo
- Declining Onchocerca volvulus transmission despite limited ivermectin delivery in the Kakoi–Koda focus, Ituri, Democratic Republic of the Congo: An epidemiological, entomological and landscape evidence synthesis
BibTeX
@article{bobga2026mpox,
title = {{Mpox 7-1-7 diagnostic and sequencing targets in the Democratic Republic of the Congo}},
author = {PB Bobga and KP Papy and BA Mandja Makasa and BO Bianpambe and JO Otshudiandjeka and SK Sawadogo and LS Sembuche and JK Kaseya},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.813},
url = {https://doi.org/10.1093/eurpub/ckag169.813},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Mpox 7-1-7 diagnostic and sequencing targets in the Democratic Republic of the Congo
AU - PB Bobga
AU - KP Papy
AU - BA Mandja Makasa
AU - BO Bianpambe
AU - JO Otshudiandjeka
AU - SK Sawadogo
AU - LS Sembuche
AU - JK Kaseya
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.813
UR - https://doi.org/10.1093/eurpub/ckag169.813
AB - Background: Mpox remains a global public Health concern with the democratic Republic of Congo as Epicenter. The 7-1-7 agenda has as target detection within ≤7 days to respond to outbreaks. The Democratic republic of Congo (DRC), faces persistent transmission linked to gaps in surveillance and laboratory systems. This study assessed the diagnostic yield, timeliness to Mpox diagnosis, sequencing and operational determinants associated with timeliness. Methods: We conducted a retrospective analysis of National surveillance and Laboratory data (2022-2025) extracted from DHIS-2. Timeliness was defined as difference from symptom onset to Mpox diagnosis or sequencing and categorized as ≤ 7 or ≥ 7 days. Logistic regression estimated crude and adjusted odds ratios (COR, AOR) and statistical significance at p < 0.05. A cascade analysis was used to evaluate attrition across response stages. Results: A total of 30784 suspected alerts among which 11771(38.2% were validated, 9139 (77.6%) samples collected, and 2829(9.2%) tested, positivity of 951(33.61%) and 386 (40.5%) sequenced. Only 50.6 % of all samples achieved timely OPX diagnosis while 53.9% met sequencing targets. Delays in sample transport ≥3 days (AOR: 0.19, CI: 0.10-0.44, p<0.001), laboratory turnaround time >4 days (AOR: 0.15, CI: .11-0.22)) reduced the odds of timely Mpox diagnosis. Symptom to alert interval within 24-48H, alert to sample collection, Sample reception to analysis were 4.10 (C.I: 2.8-6.01), 1.73 (C.I: 0.83-4.32), 2.75 (1.85-3.5) respectively. Attrition rate between stages were 62%, 69%, 85 % and 59.41% from alerts to Sequencing. Conclusions: Mpox diagnostic and sequencing timelines in DRC within 7-1-7 framework remains remains suboptimal with operational insufficiencies as determinants. Re-enforcing early detection, specimen transport, decentralized laboratory capacity could be essential to achieve 7-1-7 tarets and improve outbreak response. Key messages: • Mpox diagnostic and sequencing timelines in the DRC remain suboptimal, with only 50.6% of cases meeting the 7-1-7 target, largely due to significant attrition between alerts and laboratory testing. • Achieving 7-1-7 targets in DRC reqires addressing operational barriers by decentralizing laboratory capacity and optimizing specimen transport to reduce critical delays in detection and response.
SN - 1101-1262
SN - 1464-360X
ER -